- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07941908
Spinal Cord Stimulation Combined With Brain-Computer Interface Rehabilitation to Improve Motor Function After Stroke (SCS-BCI Rehab)
A Study on the Efficacy Evaluation of Spinal Cord Stimulation Combined With a Brain-Computer Interface for Improving Motor Function in Patients With Post-Stroke Hemiplegia Based on Multi-Source Neurophysiological Data
This study evaluates the effects of spinal cord stimulation (SCS) combined with brain-computer interface (BCI)-assisted rehabilitation on motor function in patients with post-stroke hemiplegia using multisource neurophysiological data. In this single-group study with repeated measurements, participants undergo four weeks of SCS combined with BCI-driven upper- and lower-limb rehabilitation. Immediate motor performance is compared between SCS ON and OFF conditions under standardized tasks. Changes in motor function and multisource neurophysiological and kinematic measures are also assessed before and after rehabilitation to characterize treatment responses and explore their relationships with clinical motor improvement.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
This is a single-group study using a within-participant pre-post design with repeated measurements. The study enrolls patients with post-stroke hemiplegia who meet the clinical indications for spinal cord stimulation (SCS) surgery and require SCS treatment. Following preoperative baseline assessment, participants undergo SCS implantation based on clinical indications, followed by stimulation parameter adjustment, individualized brain-computer interface (BCI) model calibration, and rehabilitation device setup.
The study includes four weeks of SCS combined with BCI-assisted synchronized upper- and lower-limb active rehabilitation. The first week includes postoperative recovery, stimulation parameter adjustment, and early closed-loop training. During rehabilitation, the BCI system identifies motor intentions from electroencephalography (EEG) signals in real time and drives upper- and lower-limb rehabilitation robots to provide corresponding assisted movements, establishing a closed-loop process integrating motor intention, robotic assistance, and sensorimotor feedback. Training is planned for three to five sessions per week, with 45-60 minutes of effective training per session.
Repeated measurements under SCS ON and OFF conditions are performed to evaluate the immediate effects of stimulation. With BCI closed-loop tasks, robotic assistance settings, and movement requirements held constant, motor performance during affected upper-limb, lower-limb, and synchronized upper- and lower-limb tasks is compared between SCS OFF and ON conditions. At least one standardized ON/OFF comparison is conducted each week during the intervention period.
Assessments are conducted at the preoperative baseline (T0), postoperative immediate-effect assessment (T1), week-2 mid-intervention assessment (T2), week-4 endpoint assessment (T3), and follow-up (T4). Clinical motor function assessments and multisource data, including EEG, functional near-infrared spectroscopy, electromyography, electrodermal activity, upper- and lower-limb kinematics, and BCI control logs, are used to evaluate changes in motor function, cortical activity, muscle activation patterns, interlimb coordination, and BCI closed-loop performance. Relationships between objective measures and improvements in clinical motor function are also examined.
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Feng Jin, MD
- Número de teléfono: +8617685739716
- Correo electrónico: jinfengsdjn@163.com
Copia de seguridad de contactos de estudio
- Nombre: Feng Jin, MD
- Número de teléfono: +86 17685739716
- Correo electrónico: jinfengsdjn@163.com
Ubicaciones de estudio
-
-
Shandong
-
Qingdao, Shandong, Porcelana, 266033
- Reclutamiento
- Qingdao Central Hospital, University of Health and Rehabilitation Sciences
-
Contacto:
- Chao Chen, MS
- Número de teléfono: +8617853280816
- Correo electrónico: chen101343@163.com
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
The study population consists of adults aged 18 to 75 years with imaging-confirmed ischemic or hemorrhagic stroke and unilateral hemiplegia. Participants must meet the clinical indications for spinal cord stimulation (SCS) implantation and be scheduled to undergo SCS surgery for clinical reasons. They must be clinically stable and able to complete brain-computer interface (BCI) calibration, synchronized upper- and lower-limb rehabilitation assessments, and multisource physiological data collection
Descripción
Inclusion Criteria
- Age 18-75 years.
- Patients who meet the clinical indications for SCS surgery, require SCS to improve their condition, and plan to undergo the procedure at the study center.
- Ischemic or hemorrhagic stroke confirmed by CT or MRI.
- Unilateral hemiplegia with assessable motor dysfunction in both the affected upper and lower limbs.
- Stable clinical condition and ability to cooperate with SCS implantation surgery, BCI calibration, synchronized upper- and lower-limb robotic rehabilitation, and collection of all multisource physiological data.
- Adequate cognitive and comprehension abilities to complete motor imagery or motor-attempt tasks and meet the requirements for BCI modeling and closed-loop control.
- Meets the clinical indications for epidural SCS implantation based on neurosurgical evaluation.
- Body size, joint range of motion, and tolerance of sitting or standing are compatible with the safe use of upper- and lower-limb rehabilitation robots.
- Written informed consent signed by the patient or their legally authorized representative.
Exclusion Criteria
- Severe cognitive impairment, complete aphasia, or severe unilateral spatial neglect that prevents completion of all study tasks.
- Uncontrolled epilepsy or frequent seizures during the previous three months.
- Contraindications to surgery or anesthesia, including severe cardiopulmonary disease, coagulation disorders, or active systemic infection.
- Implanted electronic medical devices with electromagnetic compatibility conflicts involving the SCS system, EEG/fNIRS brain recording devices, or rehabilitation robots.
- Severe limb contracture, persistent severe pain, structural joint injury, or positional intolerance that prevents standardized synchronized rehabilitation training.
- Skin lesions or skin disorders on the head or limbs that prevent the use of EEG, fNIRS, EMG, or electrodermal sensors.
- Any other condition judged by the investigator to make participation in the study inappropriate.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: COHORT
- Perspectivas temporales: PROSPECTIVE
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
SCS Combined With BCI-Assisted Synchronized Upper- and Lower-Limb Active Rehabilitation
All participants receive SCS combined with EEG-driven BCI-assisted synchronized upper- and lower-limb active rehabilitation. After baseline assessment, SCS implantation, and parameter adjustment, participants complete four weeks of training and weekly SCS ON/OFF comparisons under consistent BCI tasks and robotic assistance settings. Clinical motor outcomes, multisource neurophysiological signals, kinematics, and BCI control logs are collected |
An epidural SCS system is used, comprising stimulation electrodes, a pulse generator or external stimulator, a programming system, and an event recording system. The clinical team determines the stimulation target according to motor impairments, surgical safety, and the established treatment plan. Standardized SCS OFF and ON comparisons are performed under consistent BCI tasks and robotic assistance settings, with stimulation parameters, motor performance, and related physiological data recorded The BCI active rehabilitation system identifies motor intention during imagery or attempted movement from real-time EEG signals and triggers corresponding assisted movements using upper- and lower-limb rehabilitation robots, forming a closed loop between motor intention, sensory feedback, and limb movement. Rehabilitation continues for four weeks, three to five times per week (preferably five), with 45-60 minutes of effective training per session. At least one standardized SCS ON/OFF comparison is performed weekly
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Difference in Immediate Motor Task Performance Between SCS ON and OFF Conditions
Periodo de tiempo: Intervention weeks 1-4 (T1-T3)
|
Motor performance during affected upper-limb, lower-limb, and synchronized upper- and lower-limb tasks is compared between SCS ON and OFF conditions, with BCI closed-loop mode and robotic assistance parameters kept consistent, to evaluate the immediate effects of SCS |
Intervention weeks 1-4 (T1-T3)
|
|
Change in Upper- and Lower-Extremity Fugl-Meyer Assessment Scores
Periodo de tiempo: Preoperative baseline (T0, 1-2 weeks before surgery) to the end of intervention week 4 (T3)
|
The Fugl-Meyer Assessment (FMA) is used to evaluate changes in upper- and lower-extremity motor function separately before and after four weeks of combined rehabilitation |
Preoperative baseline (T0, 1-2 weeks before surgery) to the end of intervention week 4 (T3)
|
|
Pearson/Spearman Correlation Between Multisource Objective Measures and Clinical Motor Improvement
Periodo de tiempo: Preoperative baseline (T0, 1-2 weeks before surgery) to the end of intervention week 4 (T3)
|
Pearson or Spearman correlation analysis will be performed to examine the correlation between multisource neurophysiological measures (EEG, fNIRS, EMG, electrodermal), kinematic parameters, and BCI closed-loop performance metrics, and the change in Fugl-Meyer Assessment (FMA) score, to identify objective features linked to the effects of combined rehabilitation. |
Preoperative baseline (T0, 1-2 weeks before surgery) to the end of intervention week 4 (T3)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in 10-Meter Walk Test Speed
Periodo de tiempo: T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)
|
Walking ability is assessed using the 10-Meter Walk Test. |
T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)
|
|
Change in Modified Ashworth Scale Scores
Periodo de tiempo: T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)
|
Changes in spasticity of the affected upper and lower limbs are assessed using the Modified Ashworth Scale |
T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)
|
|
Changes in Motor-Related EEG Features
Periodo de tiempo: T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).
|
Changes in movement-related EEG rhythms, movement-related cortical potentials, and motor intention decoding features are assessed |
T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).
|
|
Changes in Motor-Area fNIRS Hemodynamic Responses
Periodo de tiempo: T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).
|
Changes in motor-area hemodynamic responses during motor tasks are assessed using functional near-infrared spectroscopy (fNIRS) |
T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).
|
|
Changes in Upper- and Lower-Limb EMG Activity and Muscle Synergies
Periodo de tiempo: T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).
|
Changes in target-muscle activation, active contribution, abnormal muscle synergies, co-contraction, and interlimb temporal coupling are assessed using upper- and lower-limb electromyography (EMG) |
T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).
|
|
Changes in Electrodermal Responses and Stimulation Tolerability
Periodo de tiempo: T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), including assessments during the 4-week intervention period
|
Electrodermal responses and stimulation tolerability are evaluated using electrodermal signals and records of stimulation-related discomfort |
T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), including assessments during the 4-week intervention period
|
|
Changes in Upper- and Lower-Limb Kinematics and Coordination
Periodo de tiempo: T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).
|
Changes in movement speed, smoothness, trajectory deviation, joint range of motion, gait or pedaling symmetry, and interlimb coordination are assessed |
T0 (1-2 weeks before surgery) to T4 (4 weeks after SCS electrode removal), with assessments at 1 week post-surgery (T1), end of intervention week 2 (T2), end of intervention week 4 (T3).
|
|
BCI Decoding and Closed-Loop Control Performance
Periodo de tiempo: From initial BCI calibration (T0, 1-2 weeks before surgery) to end of intervention week 4 (T3), with follow-up assessment at T4 (4 weeks after SCS electrode removal)
|
BCI performance is evaluated using decoding accuracy, valid trigger rate, false trigger rate, control latency, robotic task completion rate, assistance level, and online model stability |
From initial BCI calibration (T0, 1-2 weeks before surgery) to end of intervention week 4 (T3), with follow-up assessment at T4 (4 weeks after SCS electrode removal)
|
|
Safety, Training Completion, and Data Acquisition Quality
Periodo de tiempo: During the 4-week intervention after SCS implantation, with final assessment at T4 (4 weeks after SCS electrode removal)
|
SCS-, BCI-, and robotic device-related adverse events, training completion, device tolerability, and the completeness and quality of synchronized upper- and lower-limb data acquisition are recorded |
During the 4-week intervention after SCS implantation, with final assessment at T4 (4 weeks after SCS electrode removal)
|
|
Change in Berg Balance Scale Score
Periodo de tiempo: T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)
|
Balance function is assessed using the Berg Balance Scale. |
T0 (1-2 weeks before surgery), T3 (end of intervention week 4), and T4 (4 weeks after SCS electrode removal)
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Feng Jin, MD, Qingdao Central Hospital, University of Health and Rehabilitation Sciences
Publicaciones y enlaces útiles
Publicaciones Generales
- Liu H, Yang L, Wang H, et al. Spinal Cord Stimulation for Poststroke Hemiparesis: A Scoping Review of Upper and Lower Limb Efficacy. Arch Phys Med Rehabil. 2024;105(8):1521-1532
- Chen D, Shi J, Tao B, Zhao X, Zhao Z, Li S, Xu Y, Ding T, Zhang P, Ye Q, Chen K, Wu Z, Tang Y, Jiang W, Shu K, Huang L, You Z, Zhang P, Tang Z. A Novel Transfer Learning-Based Hybrid EEG-fNIRS Brain-Computer Interface for Intracerebral Hemorrhage Rehabilitation. Adv Sci (Weinh). 2025 Nov;12(43):e05426. doi: 10.1002/advs.202505426. Epub 2025 Aug 19.
- Kathe C, Skinnider MA, Hutson TH, Regazzi N, Gautier M, Demesmaeker R, Komi S, Ceto S, James ND, Cho N, Baud L, Galan K, Matson KJE, Rowald A, Kim K, Wang R, Minassian K, Prior JO, Asboth L, Barraud Q, Lacour SP, Levine AJ, Wagner F, Bloch J, Squair JW, Courtine G. The neurons that restore walking after paralysis. Nature. 2022 Nov;611(7936):540-547. doi: 10.1038/s41586-022-05385-7. Epub 2022 Nov 9.
- Liang J, Song Y, Belkacem AN, Li F, Liu S, Chen X, Wang X, Wang Y, Wan C. Prediction of balance function for stroke based on EEG and fNIRS features during ankle dorsiflexion. Front Neurosci. 2022 Aug 18;16:968928. doi: 10.3389/fnins.2022.968928. eCollection 2022.
- Bastos T, Villa-Parra AC, Guerrero-Méndez CD, et al. Towards Upper- and Lower-Limb Rehabilitation of Post-Stroke Patients through Brain-Computer Interface, Cerebrospinal Stimulation and Robotic Devices. In: Biosystems and Biorobotics. Springer; 2024:689-692
- Alawieh H, Liu D, Madera J, Kumar S, Racz FS, Fey AM, Del R Millan J. Electrical spinal cord stimulation promotes focal sensorimotor activation that accelerates brain-computer interface skill learning. Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2418920122. doi: 10.1073/pnas.2418920122. Epub 2025 Jun 10.
- Li R, Li S, Roh J, Wang C, Zhang Y. Multimodal Neuroimaging Using Concurrent EEG/fNIRS for Poststroke Recovery Assessment: An Exploratory Study. Neurorehabil Neural Repair. 2020 Dec;34(12):1099-1110. doi: 10.1177/1545968320969937. Epub 2020 Nov 16.
- Privitera L, Lassi M, Dalise S, Azzollini V, Maggiani L, Guggisberg A, Mazzoni A, Chisari C, Micera S, Bandini A. A multimodal machine learning approach to forecast upper limb motor recovery after stroke using kinematic and electromyographic data - A pilot-study. J Neuroeng Rehabil. 2026 Jan 5;23(1):31. doi: 10.1186/s12984-025-01796-5.
- Ali U, Khan JA, Ahsan MT, Altaf B, Azreen S, Alamu OS, Rana MS. Brain-Computer Interfaces in the Rehabilitation of Stroke and Spinal Cord Injury: A Systematic Review and Meta-Analysis of Clinical Efficacy. Cureus. 2025 Oct 17;17(10):e94833. doi: 10.7759/cureus.94833. eCollection 2025 Oct.
- Powell MP, Verma N, Sorensen E, Carranza E, Boos A, Fields DP, Roy S, Ensel S, Barra B, Balzer J, Goldsmith J, Friedlander RM, Wittenberg GF, Fisher LE, Krakauer JW, Gerszten PC, Pirondini E, Weber DJ, Capogrosso M. Epidural stimulation of the cervical spinal cord for post-stroke upper-limb paresis. Nat Med. 2023 Mar;29(3):689-699. doi: 10.1038/s41591-022-02202-6. Epub 2023 Feb 20.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Manifestaciones neurológicas
- Trastornos cerebrovasculares
- Enfermedades Cerebrales
- Enfermedades del Sistema Nervioso Central
- Enfermedades del Sistema Nervioso
- Enfermedades Vasculares
- Enfermedades cardiovasculares
- Parálisis
- Condiciones Patológicas, Signos y Síntomas
- Signos y síntomas
- Carrera
- Hemiplejía
- Terapéutica
- Modalidades de fisioterapia
- Rehabilitación
- Terapia de estimulación eléctrica
- Estimulación de la médula espinal
Otros números de identificación del estudio
- KY202614801
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Individual participant data will not be shared with external researchers. Study data will be used for analyses within this research project. Study findings will be reported in aggregate form while protecting participant privacy
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .